Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464178
Status:
TERMINATED
Last Update Posted:
2022-07-20
First Post:
2007-04-19
Brief Title:
A Phase II Study of Bevacizumab and Bortezomib in Patients With RelapsedRefractory Multiple Myeloma
Sponsor:
Hackensack Meridian Health
Organization:
Hackensack Meridian Health
Organization Data
Organization:
Hackensack Meridian Health
Class:
OTHER
Study ID:
AV3502s
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hackensack Meridian Health
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |